Aberrant signaling by growth factor receptor tyrosine kinases (RTKs) is responsible for many human diseases, from cancer to developmental and metabolic defects. The relevant pathologies are often associated with receptor mutations or inappropriate expression of growth factors (Robertson et al., 2000) . In either case, unraveling the mechanisms of RTK signaling should help to illuminate useful avenues for the design of new therapeutics.
An excellent example is provided by Kit, a class III RTK that is expressed by many cell types including hematopoietic stem cells. Kit is activated by a cytokine ligand known as stem cell factor (SCF). Pathological mutations in both the extracellular and intracellular domains of Kit have been identified. Gain-of-function mutations are associated with gastrointestinal stromal tumors and other cancers, whereas mutations that cause loss of function lead to piebaldism, a disorder of melanocyte development (Robertson et al., 2000) . Structural studies of the intracellular domains of Kit and other class III RTKs explain how both inactivating and activating mutations are likely to achieve their effects (Robertson et al., 2000) . Many of the activating Kit mutations associated with gastrointestinal stromal tumors are found in the intracellular "juxtamembrane" region of the receptor. This ~35 amino acid region, between the transmembrane helix and the intracellular domain, interacts intimately with the kinase domain and stabilizes an inactive configuration, thus "autoinhibiting" the receptor (Hubbard, 2004) . Many clinically observed mutations that activate Kit and other class III receptors are predicted to disrupt these autoinhibitory interactions. In addition to these intracellular juxtamembrane mutations, clinically important activating mutations are also found in the membrane-proximal part of the Kit extracellular region. Now, in this issue of Cell, Schlessinger and his colleagues (Yuzawa et al., 2007) In this issue, Schlessinger and his colleagues (Yuzawa et al., 2007) describe crystal structures of the complete extracellular region of the Kit receptor tyrosine kinase, both alone and in complex with its activating ligand, stem cell factor (SCF). The structures explain how SCF drives dimerization of the receptor. They also reveal important receptor-receptor contacts that may explain how several Kit mutations lead to cancer.
vating and inactivating extracellular mutations influence Kit function. The structures also provide important insight into the normal mechanism of SCF-mediated Kit activation.
From previous studies of RTK activation, mechanisms of ligandinduced dimerization can be classified into "ligand-mediated" and "receptor-mediated" groups. RTKs with immunoglobulin-like (Ig-like) domains in their extracellular regions (Kit has five) tend to fall into the ligand-mediated class in which a bivalent ligand binds simultaneously to two receptors and effectively "crosslinks" them into a dimer. In such cases, the growth factor ligand (alone or bound to an accessory molecule) directly forms the dimer interface (Stroud and Wells, 2004) . A stark contrast to this scenario is provided by the epidermal growth factor (EGF) receptor family of RTKs, for which dimerization is entirely receptor mediated (Burgess et al., 2003) . In the EGF receptor, the bound growth factors are distant from the dimer interface, and their binding promotes a dramatic domain rearrangement that exposes a dimerization site in the extracellular region of the receptor.
The two new structures of the Kit extracellular region (Yuzawa et al., 2007) show that Kit is in the ligand-mediated camp. Indeed, this was anticipated given the five Iglike domains in the Kit extracellular region and the known dimeric fourhelix bundle structure of SCF. Each SCF molecule in the dimer binds to the first three Ig-like domains (D1, D2, D3) of Kit, nicely explaining clinical and experimental loss-of-function mutations in this region (Liu et al., 2007; Yuzawa et al., 2007) . Comparing the structures of the free and ligand-bound forms of Kit, Yuzawa et al. (2007) show that SCF binding induces no significant conformational changes in the D1-D3 region of Kit. Each individual domain is largely unaltered and the relationship between the three Ig-like domains remains fixed whether or not ligand is bound, suggesting that the D1-D3 region of Kit is "poised" for binding to SCF. Interestingly, it is also a feature of the EGF receptor that growth factor binding does not induce significant conformational changes in the individual ligandbinding domains (Burgess et al., 2003) .
An SCF dimer directly bridges two Kit molecules, and there are no contacts between the two receptor molecules in the D1-D3 region (Figure 1 ; Liu et al., 2007; Yuzawa et al., 2007) . In this sense, Kit dimerization is clearly ligand-mediated. However, there are clear contacts between the two receptor molecules in the membraneproximal region of the dimer, involving domains D4 and D5 (Yuzawa et al., 2007) . The left-most structure in Figure 1 shows how the ligand-mediated dimer would appear if the relationship between the five Ig-like domains was completely fixed. Comparison with the actual SCF/Kit dimer structure (Figure 1, middle; Yuzawa et al., 2007) reveals significant reorientation of the D4 and D5 domains that brings both domains very close to the dimer interface. The two D4 domains in a dimer (Yuzawa et al., 2007) , in which the two D4 and D5 domains in the dimer are in close proximity. Without reorientation of the D4 and D5 domains, the receptors in the dimer are separated by 75 Å at the membrane. Following D4/D5 reorientation, their C termini are separated by just 15 Å-a reasonable separation if the transmembrane α helices also interact intimately with one another. (Right) For comparison is shown a structural representation of a dimer of the extracellular region of the epidermal growth factor receptor (EGFR); dimer formation is induced by EGF. The membrane-proximal domain of this receptor (domain IV) has not been visualized directly in the dimer, but its location has been modeled based on known ligand-free configurations (Burgess et al., 2003) . The studies of Kit by Yuzawa et al. (2007) suggest that weak interactions between membrane-proximal domains can play a critical role in defining the relative orientation of the two receptor tyrosine kinase molecules in the dimeric complex, and their close approach at the membrane surface, which is required for transmembrane signaling.
interact directly with one another, while D5-D5 interactions may be water mediated (Yuzawa et al., 2007) . This "twist" in the receptor indicates that with Kit there are ligand-induced receptor-receptor interactions in an otherwise ligand-mediated receptor dimer. How important are these receptor-mediated interactions? How much does this finding blur the distinction between ligand-mediated and receptor-mediated dimerization?
It has been shown that an antibody against domain D4 blocks SCF-induced Kit activation (Blechman et al., 1995) , supporting the idea that the two D4 domains must be in close proximity in the active dimer. Yuzawa et al. (2007) note that the residues involved in direct D4-D4 interactions, most prominently an intermolecular salt bridge, are conserved in the D4 domains of other type III RTKs. Intriguingly, these residues are also conserved in the membrane-proximal Ig-like domains of type V (VEGF receptor) RTKs that have seven such domains. The authors demonstrate that mutating residues involved in the central D4-D4 salt bridge impairs Kit signaling but without affecting dimerization itself. Indeed, earlier studies in solution showed that the absence of both the D4 and D5 domains does not reduce SCF-induced Kit dimerization (Lemmon et al., 1997) . Thus, it seems clear that the D4-D4 interactions are important for Kit signaling, but they are not required for driving receptor dimerization per se. The interactions are centered on a single pair of salt bridges, which need not contribute positively to (and may actually even oppose) dimerization (Sheinerman and Honig, 2002) . Such weak membrane-proximal interactions between the two Kit molecules in a homodimer are likely to be driven by SCFinduced dimerization of the D1-D3 region and could play an important role in defining the relative orientations of the two receptors (rather than aiding dimerization itself). An orientational role of this sort could be critical for linking Kit dimerization to activation of its kinase domain (via allosteric changes in the intracellular juxtamembrane region). This notion of a specific configuration for the activation-competent dimer is also supported by the intriguing observation that almost all activating oncogenic mutations found in the Kit extracellular region (in gastrointestinal stromal tumors and other cancers) map to the dimer interface of D5. Although the precise basis for the effects of these mutations is not clear, it seems likely that they promote aberrantly strong interactions between D5 domains in this region. Dimerization of Kit molecules harboring these mutations would therefore be pathologically receptor mediated (rather than ligand mediated), leading to elevated constitutive activity and promoting tumorigenesis.
Structural studies of other RTKs have left unclear the details of extracellular membrane-proximal regions. No membrane-proximal interactions are seen in the ligand-induced dimer of the fibroblast growth factor (FGF) receptor (Schlessinger et al., 2000) , and the two molecules in the homodimer are predicted to be separated by ~40 Å at the membrane (compared with 15 Å for Kit). In the EGF receptor, crystallographic studies failed to discern the precise location of the most membrane-proximal domain in the extracellular region, although some data suggest that it plays an important role in EGFR signaling (Burgess et al., 2003) , if not in actually stabilizing the receptor dimer. The EGFR dimer is depicted in Figure 1 , with the hypothetical location of its most membrane-proximal domain (domain IV) shown in outline. This model places the two receptor molecules of the dimer 15-20 Å apart at the membrane and, together with crystallographic studies (Burgess et al., 2003) , suggests very weak receptor-receptor interactions in this region. The SCF/Kit dimer structure presented in the Yuzawa et al. study presents us with a glimpse of the type of weak interactions that can be important in this part of RTK extracellular regions, and how they can play a critical role in normal and pathological RTK signaling. With clear views of RTK kinase domains (inactive and activated) and ligandbinding domains, the challenge for the future is to understand precisely how these two regions are linked. The structure reported by Yuzawa et al. (2007) together with the structure of the Kit kinase domain (reviewed in Hubbard, 2004) leaves just 36 intervening amino acids to account for (including the transmembrane domain) and brings us close to fully understanding the details of transmembrane signaling by this important receptor.
